SOURCE: True 2 Beauty Inc.

October 04, 2010 09:11 ET

True 2 Beauty, Inc. Acquires Worldwide Exclusive License to Manufacture and Distribute Libigrow Family of Products

LOS ANGELES, CA--(Marketwire - October 4, 2010) -  True 2 Beauty Inc., (PINKSHEETS: TRTB) (the "Company"), a now leading manufacturer and distributor of male sexual potency pills and liquid products in the United States, announced today it has entered into an Intellectual Property License Agreement to acquire the worldwide rights to the "Libigrow" family of products. www.libigrow.com.

Pursuant to the terms of the IP Licensing Agreement, the Company has acquired an exclusive, worldwide, and royalty-free license to manufacture and distribute the Libigrow line of pills and liquid products including Libigrow, Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink in exchange for a total of one hundred and sixty million shares of its restricted stock.

Alex Hbaiu, President and CEO of True 2 Beauty, Inc., stated, "We are excited about the agreement with Libigrow and look forward to expanding our market reach in the U.S. and around the world for the Libigrow family of products."

Concurrently with the IP Licensing Agreement, the Company has moved its corporate offices to:

True 2 Beauty, Inc.
3183 Wilshire Blvd, Suite 196 A13
Los Angeles, CA 90010
Telephone: 1-888-942-5350

About True 2 Beauty, Inc.

True 2 Beauty, Inc. is a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States. The True 2 Beauty, Inc. line of current products include Libigrow, Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink. More information on the Company and its line of products can be found at www.libigrow.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, among others, all assumptions, expectations, predictions, intentions or beliefs about future events. You are cautioned that any such forward- looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause actual results of the Company to differ materially from those anticipated, expressed or implied in the forward- looking statements. The words "believe," "expect," "anticipate," "project," "targets," "optimistic," "intend," "aim," "will" or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those anticipated include risks related to new and existing products, product defects and any related product recall; any projections of sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements .The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.

Contact Information

  • For further information, please contact:
    Investors Relations Contact:
    New York World Asset Management
    (702) 436-4562

    Media Relations:
    Zara Hbaiu
    zara@libigrow.com
    (888) 942-5350